Nurr1 as a genetic target for treating levodopa-induced dyskinesias in Parkinson's disease
Methods of treating movement disorders by reducing the activity of Nurr1 are disclosed.
These methods are particularly applicable to subjects suffering from Parkinson's disease …
These methods are particularly applicable to subjects suffering from Parkinson's disease …